van der Kleijn E, Vree TB, Baars AM, Wijsman R, Edmunds LC, Knop HJ. Factors influencing the activity and fate of benzodiazepines in the body.
Br J Clin Pharmacol 1981;
11 Suppl 1:85S-98S. [PMID:
6133540 PMCID:
PMC1401632 DOI:
10.1111/j.1365-2125.1981.tb01843.x]
[Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
Abstract
1 The clinical pharmacokinetics of the many benzodiazepines used to treat numerous and varied clinical conditions can be influenced by many factors. 2 Combinations of drugs efficacious in the central nervous system can change the onset, intensity and duration of effect as a result of pharmacological, physiological and pharmacokinetic actions. 3 Pharmacokinetic considerations indicate that short to medium long-acting benzodiazepines that depend on only glucuronidation for their major metabolic pathway are the drugs of choice in this category.
Collapse